Request Deal Involvement

STADA completed the acquisition of Takeda’s OTC portfolio in Russia/CIS for $660m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ernst & Young

financial advisors

Ernst & Young

Ernst & Young

accounting advisors

Ernst & Young

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Nomura

financial advisors

Nomura

Bank of America

financial advisors

Bank of America

White & Case

legal advisors

White & Case

or

Principals

TAKEDA PHARMACEUTICAL COMPANY LIMITED (OTC PORTFOLIO)

target

TAKEDA PHARMACEUTICAL COMPANY LIMITED (OTC PORTFOLIO)

STADA ARZNEIMITTEL AG

bidder

STADA ARZNEIMITTEL AG

TAKEDA PHARMACEUTICAL COMPANY LIMITED

vendor

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - STADA completed the acquisition of Takeda’s OTC portfolio in Russia/CIS for $660m.